Haemonetics Corp (HAE)
77.14
+1.70
(+2.25%)
USD |
NYSE |
Dec 23, 16:00
77.90
+0.76
(+0.99%)
After-Hours: 17:59
Haemonetics Free Cash Flow: 20.35M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp | 1.892B |
| ResMed Inc | 1.347B |
| Globus Medical Inc | 293.77M |
| Baxter International Inc | 391.00M |
| Abbott Laboratories | 6.486B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 48.82M |
| Cash from Investing (Quarterly) | -23.37M |
| Cash from Financing (Quarterly) | -74.80M |
| Free Cash Flow Per Share (Quarterly) | 0.7687 |
| Free Cash Flow to Equity (Quarterly) | 38.02M |
| Free Cash Flow to Firm (Quarterly) | 44.68M |
| Free Cash Flow Yield | 0.51% |